A Novel Gene Signature to Predict Survival Time and Incident Ventricular Arrhythmias in Patients with Dilated Cardiomyopathy

<div>Validation of the survival time prognostic risk models in NIDCM patients. (a) Survival analysis of symptoms to heart transplantation in the high-risk (red line) and low-risk (blue line) NIDCM patients. (b) Time-dependent ROC curve analyses show AUC values for time from symptoms to heart transplantation in NIDCM patients. (c) Expression levels of risk genes in the high-risk and low-risk patients.</div>

Disease Markers

fig3

Figure 3

Figure 3: A Novel Gene Signature to Predict Survival Time and Incident Ventricular Arrhythmias in Patients with Dilated Cardiomyopathy 